LANXESS has reported a robust 19.9% rise in EBITDA pre exceptionals to EUR 614 million in 2024, driven by its FORWARD! cost-saving initiative and improved operational efficiency. While sales declined by 5.2% to EUR 6.366 billion due to lower raw material prices, higher capacity utilization helped improve profitability, pushing the EBITDA margin to 9.6%, up from 7.6%.
The company’s net financial debt decreased by 4.7%, thanks to strong free cash flow of EUR 188 million. LANXESS plans to maintain a stable dividend of EUR 0.10 per share for the fiscal year.
Looking ahead, LANXESS expects 2025 EBITDA pre exceptionals to reach EUR 600–650 million, reflecting around 10% operational growth. The sale of the Urethane Systems business, set to close in April 2025, marks the completion of LANXESS’ transformation into a pure specialty chemicals company.
Segment highlights:
-
Advanced Intermediates: EBITDA up 73.6% to EUR 210 million
-
Specialty Additives: EBITDA rose 8.6% despite price drops
-
Consumer Protection: EBITDA dipped slightly amid agrochemical demand weakness
